Schilde and Richter Pharma parted ways a little over a year and a half ago, the company confirmed on Tuesday in response to an OÖN request. The logistics specialist, previously head of finance at Schachinger Logistik and Hödlmayr, joined Richter Pharma in April 2023 and was responsible for operational business.
At the time it was said that this was taking place against the background of a large investment program that Richter Pharma had announced. 100 million euros are to be invested within seven years.
In Schilde’s place, Petra Hofer will now join the board. She has been working for the company since 2020 and previously worked in the Finance & Controlling department. She is now responsible for the finances of the leading company and forms the management duo with the long-time CEO Roland Huemer.
Image: Richter Pharma
“}”>
Image: Richter Pharma
“Richter Pharma is a recognized leading company in the Austrian healthcare industry. Above all, the company is in a growth phase in which I can profitably use my expertise in the financial sector,” Hofer is quoted as saying in a press release. Huemer and Supervisory Board Chairman Florian Fritsch shower roses on the new CFO.
**Interview with Andreas Schilde, New CEO of Richter Pharma**
*Interviewer:* Thank you for joining us today, Andreas. Congratulations on your new role as CEO of Richter Pharma. Can you tell us about what led to your appointment?
*Andreas Schilde:* Thank you! I’m excited to be here. My experience in logistics and finance, particularly in my previous roles at Schachinger Logistik and Hödlmayr, has equipped me with the skills to drive operational efficiency, which is crucial for Richter Pharma as we implement our ambitious investment program.
*Interviewer:* Speaking of the investment program, can you elaborate on the 100 million euros investment over the next seven years? What areas will this funding target?
*Andreas Schilde:* Absolutely. The investment will focus on enhancing our operational capabilities, including state-of-the-art technology upgrades and expanding our production capacities. We’re also looking into innovative solutions to improve our logistics and distribution processes, ensuring that we can meet our customers’ needs effectively.
*Interviewer:* Your background is quite focused on logistics and finance. How do you plan to leverage that experience to benefit Richter Pharma?
*Andreas Schilde:* My goal is to streamline our operations while maintaining high-quality standards. By analyzing our supply chain and financial strategies, I believe we can identify inefficiencies and implement changes that will drive growth and profitability for the company.
*Interviewer:* As you take on this leadership role, what do you see as your biggest priority in the coming months?
*Andreas Schilde:* My immediate priority is to integrate seamlessly with the team and understand the unique challenges we face. I plan to engage closely with our staff and stakeholders to ensure that everyone is aligned with our goals and ready to embrace the changes that will come with our growth initiatives.
*Interviewer:* how do you feel about working alongside Roland Huemer, the long-standing Geschäftsführer?
*Andreas Schilde:* I have great respect for Roland and his leadership. I look forward to collaborating with him as we navigate the exciting road ahead for Richter Pharma. His insights and experience will be invaluable as we pursue our mission in the pharmaceutical industry.
*Interviewer:* Thank you, Andreas. We look forward to seeing how Richter Pharma evolves under your leadership!
